The diagnosis and management of invasive fungal infections in adult patients with hematological malignancies remains a ...

A sugar on mycobacteria binds to the immune receptor dectin-1 on host macrophages, helping the bacteria survive and driving ...

Basilea Pharmaceutica has entered into a strategic collaboration with Prokaryotics to develop a first-in-class broad-spectrum antifungal therapy targeting severe invasive fungal infections. The ...

Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infectives ...

Allschwil, Switzerland, January 07, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Scientists from the Royal Botanic Gardens, Kew, and their international partners, reveal today their pick of the top 10 ...

Human Microbiome Market OverviewThe human microbiome market is witnessing exceptional momentum and is projected to grow at an impressive CAGR of 31% over the forecast period.Key Request a free sample ...

When weird fungal epidemics crop up in far-flung places, scientists work together to unravel how the microscopic murderers show up and turn deadly. The Great Alaska Earthquake rocked Anchorage in 1964 ...

The fungal species Candida auris is spreading across the globe, and gaining in virulence, according to a new review by a ...

A drug-resistant variety of the common fungus Candida auris is gaining virulence and spreading across the globe, scientists warn in a new review. Fungal infections, which affect nearly 6.5 million ...